The California Institute for Regenerative Medicine (CIRM) has awarded $9 million to Loma Linda University Health to create a ...

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...

Please provide your email address to receive an email when new articles are posted on . VG801 is a dual-AAV gene therapy in development for the treatment of Stargardt disease. The therapy is under ...

The Ministry of Health and Welfare and the Regenerative Medicine Advanced Foundation will hold the '2025 RMAF Annual ...

Despite challenges like high production costs and uneven regulations, the region is set to become a hub for cutting-edge ...

Often described as ‘miracle’ cells, stem cells need to be truly mastered if we’re to use them in medical treatments.

GC Cell announced on the 31st that its HER2-targeted allogeneic CAR-NK cell therapy, 'AB-201 (GCC2003),' has received simultaneous approvals for its ...

Planarian stem cells can be “independent” and turn into any type of cell without needing a nearby niche, a new study indicates.

Biomedical experts and practitioners in North Carolina are developing technology to rebuild skin and repair damaged organs, and they think it can be used to heal injuries on the battlefield. “You have ...

THE Asian Society for Regenerative Medicine (ASRM) proudly announces its 2nd Annual Convention and Workshop, happening at ...